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ABSTRACT
Latin hypercube sampling and Partial Rank Correlation Coefficient procedure (LHS/
PRCC) can be used in combination to perform a sensitivity analysis that assesses
a model over a global parameter space. Through this analysis, the uncertainty of
the parameters and therefore the variability of the model output in response to this
uncertainty can be observed. Latin hypercube sampling divides the parameter space
into equiprobable regions and samples without replacement, producing a global, un-
biased selection of parameter values. For monotonic, non-linear relationships, the
correlation between the outputs and parameters can be understood by performing a
Partial Rank Correlation Coefficient procedure. This sensitivity analysis is applied to
ordinary differential equation models describing the interactions of various biological
components in the healing of a diabetic foot ulcer. The results of the LHS/PRCC
sensitivity analysis are used to assess the biological significance of the parameters in
relation to each compartment of the model to further understand its biological impli-
cations.
Keywords: Wound Healing, Latin hypercube sampling, Partial Rank Correlation Co-
efficient procedure, Uncertainty, Sensitivity Analysis
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CHAPTER 1
Introduction
Mathematical models have recently become increasingly popular tools to describe
real world phenomena. Through these models, we can efficiently and inexpensively
simulate, understand, and establish baseline characteristics of a system. In biology,
these models are often used to describe population ecology (such as predator-prey
models) or disease transmission (such as SIR models). At the molecular level, we can
use mathematical models to understand processes such as tumorogenesis or wound
healing. Applications of mathematics to these and other biological processes provide
an entire understanding of the complex systems.
Models in molecular biology often describe the concentration of proteins or cell
count as they change over time and space. Parameters in these types of models
represent empirically observable quantities such as production and decay rates. A
qualitative model uses estimates for parameter values that can capture the general
behavior of how the cells and proteins change over time. In contrast, a quantitative
model is constructed using data; comparisons allow the accuracy of the model to be
objectively evaluated. While information can be obtained from both types of model,
we are more confident in our model predictions for experimental procedures when
using quantitative models.
In this work we use a mathematical model to describe the systems that comprise
the healing wound. Specifically, we focus on chronic wounds, which are wounds
that do not heal in a timely manner. While there are several options for treatment,
1
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including structure dressing and oxygen therapy, treatment is often defined by the
type of chronic wound, such as a diabetic foot or leg ulcer. However, the response to
treatment varies significantly from patient to patient.
Developing strategies to understand the healing response due to a particular treat-
ment for each individual patient should be of primary importance. Identifying strate-
gies to individualize treatment for each patient can significantly reduce the cost of
treatment, estimated at reducting $5 – 10 billion per year in the United States –
mathematical modeling provides a means. However, current mathematical models
for wound healing are limited by the qualitative approach for model developemnt,
preventing such usage in the clinical setting; the healing of chronic wounds has been
seldom modeled using quantitative methods that rely on patient data. By incorpo-
rating individual patient data through model parameters, we can formulate a model
to be used in a clinical setting to analyze possibilties for personalized treatment.
In this work, three different models are presented. The first, part of a paper
submitted for publication, describes the interactions of matrix metalloproteinase and
their inhibitors with extracellular matrix during dermal repair of a diabetic foot ulcer.
We solve and analyze an inverse problem for the constructed model. Through numeri-
cal methods which attempt to minimize the difference between data and model curve,
estimates can be determined for each parameter. The results can provide insight into
the underlying mechanisms and interactions.
In the second chapter, an extended model is suggested which incorporates a uni-
versally functional growth factor, transforming growth factor beta (TGF–β). TGF–β
is responsible for the regulation of production for many proteins and cells, further
coupling the previously presented equations. Parameters were re–estimated for the
extended model.
Using a different approach to the wound healing process, a model formulated by
my mentor, Dr. Richard Schugart, models the process by describing the immune
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system response to a bacterial infection with respect to oxygen concentration. Many
parameters for this model were previously estimated in the literature.
The formulation of any mathematical model is incomplete without analysis. The
noisy nature of biological data demands the use of uncertainty analyses to determine
the propensity of this “noise” to propogate to the model output – the ability of un-
certainty of an input vector to cause uncertainty in the output. By replicating the
noise in the original data, we can observe the changes in the output and determine
which inputs have the strongest effect and on which parts of the model. Interpre-
tation of the results of this analysis can reveal limitations of the model and allow
for modification to minimize uncertainty. We assess the three models discussed us-
ing a Latin Hypercube Sampling/Partial Rank Correlation Coefficient procedure to
determine parameter uncertainty and sensitivity.
CHAPTER 2
MMP–1/TIMP–1 Model
The work shown below details the construction, parameter estimation, and anal-
ysis of a model describing the interactions for matrix metalloproteinase and its in-
hibitors. My work on this model includes parameter estimation, a global sensitivity
analysis, and the “local–to–global” analysis, as well as the expanded introduction.
Work by Nitin Krishna, an alumnus of the Gatton Academy who also worked under
Dr. Schugart, is included. His contributions include the local sensitivity analyses, a
steady state analysis, and work on the parameter estimation. This work, titled “Con-
necting Local and Global Sensitivities for a Mathematical Model in Wound Healing”,
was submitted to the Bulletin of Mathematical Biology (Manuscript Number BMAB–
D–15–00112) and is in review.
2.1 Introduction
Injury to the dermal layer of the skin requires the body to respond quickly in order
to repair and regenerate broken skin. In an acute wound, healing typically progresses
through four stages: hemostasis, inflammation, proliferation, and remodeling [22].
Each stage depends on the proper balance of several proteins and cells in the wound.
The careful maintenance of the levels of these components contributes to the complex
interactions that define the healing response of a wound. A perturbation to this
biological system can have a serious effect on the healing of the wound.
4
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The first stage, hemostasis, is characterized by the clotting of the wound, preven-
tion of blood loss, and blockage of damaged vessels. The resulting vasoconstriction at
the wound site is immediately followed by histamine-regulated vasodilation, which in-
creases the permeability of the blood vessels in the area [17]. Simultaneously, platelet
aggregation leads to the release of many cytokines, especially growth factors such as
transforming growth factor beta (TGF-β), acting as chemoattractants for the recruit-
ment of neutrophils and monocytes [39]. The arriving neutrophils may then permeate
the vascular membrane to enter the damaged tissue, functioning as an immunological
reaction to exposure by phagocytizing waste and dead tissue. This migration marks
the beginning of the inflammatory phase. The later arrival of monocytes is concurrent
with their transformation into macrophages. These leukocytes phagocytize present
neutrophils, bacteria, and dead tissue following activation through T lymphocyte
signaling [17].
The growth factors secreted by these activated macrophages recruit mesenchymal
and endothelial cells, marking the beginning of the proliferative phase. Fibroblasts,
a type of mesenchymal cell, must migrate from nearby tissue to the wound site,
where they take on the primary role of producing collagen and other fibrous proteins
during dermal repair [17]. This type of repair denotes the reconstruction of the deeper
reticular dermis, the layer of skin comprised of extracellular matrix (ECM) that serves
as as connective tissue [22]. Collagen, the most abundant protein of ECM, is produced
by fibroblasts and acts as the major support structure for the surrounding layers of
skin. The formation of the new matrix requires the degradation of damaged matrix
components or obstructive bodies in the ECM. Mediators, proteins that activate
these cells by acting as a molecular signal to control their release, are responsible
for the timing of such events during each stage. Many mediators, such as TGF-β,
stimulate the secretion of proteolytic enzymes by fibroblasts, which can clear a path
for migration through the ECM [17].
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Among these enzymes are matrix metalloproteinases (MMPs), a family of en-
dopeptidases present at low levels except during wound healing [44]. Once they are
activated, MMPs are able to degrade the ECM obstructing the fibroblasts and thus
become critical to the proliferation and remodeling of new skin. MMPs are charac-
terized by a catalytic zinc ion; they also contain multiple structural calcium and zinc
ions integrated into their catalytic site [21]. The dissociation of a cysteine-zinc ion
bond frees the active site, activating MMPs and allowing for degradation of proteins
[16].
There are 25 isoforms of MMPs, each specializing in the breakdown of specific
proteins comprising the matrix [27]. In the wound-healing process, the subgroups
containing collagenases (MMP-1 and MMP-8) and gelatinases (MMP-2 and MMP-9)
play a crucial role [31]. Particularly, MMP-1, also known as fibroblast collagenase,
acts as the major collagenase in wound healing. MMP-1 lyses type-I, -II, and -III
collagen in order to allow fibroblast migration during remodeling and proliferation of
the tissue [25]. The heavy deposition of type-I collagen, constituting roughly 90% of
collagen in load-bearing structures such as the skin, contributes to the importance of
collagenases in wound healing [17].
Successful progression of healing heavily relies on the proper balance between the
various proteins interacting in a wound. As a major factor in the reconstruction of
the skin at the wound site, MMPs regulate formation of new ECM. Even so, excessive
levels of the enzyme may be deleterious. Conversely, lowered concentrations of MMPs
allow surplus, uncontrolled production of new ECM, which can lead to hypertrophic
scarring or fibrotic conditions such as dermal fibrosis or atherosclerosis [18]. The
implied limitation of MMP activity requires precise regulation of MMP expression,
crucial to the proper remodeling of skin at the site of the wound during dermal repair.
Most regulation of MMP occurs at the transcriptional level through signaling [27].
Expression of select isoforms of MMPs (1, 3, 8, 24) by the fibroblasts can be increased
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by factors such as stratifin, shown to activate the pathway for production of MMP-1
and -3 [42]. These proteins are released by keratinocytes, a prominent epidermal
skin cell, and promote the production of various enzymes and matrix deposition by
fibroblasts [18]. Atypical communications between keratinocytes and fibroblasts due
to low levels or distance can affect the interactions between the two, contributing to
a possible significant imbalance in the levels of MMPs [31].
Regulation of MMPs is not only controlled at the level of production, but also on
a direct inhibitory level. Tissue inhibitors of metalloproteinases (TIMPs) function by
binding the catalytic zinc atom of MMPs in a tight one-to-one complex [4]. TIMPs
are comprised of a family of four proteins (TIMP-1, -2, -3, and -4), all of which can
inhibit a majority of the MMP family. This inhibition controls the rate of breakdown
of ECM during tissue remodeling and angiogenesis. Some TIMPs have strong affinities
for specific MMPs, e.g. the relationship between concentrations of TIMP-1 and MMP-
1 [16].
The interactions of fibroblasts, MMPs, and TIMPs are critical to the successful
reconstruction of damaged skin. During the proliferative stage, fibroblasts must pro-
duce collagen at an increased rate. The heightened activity of these cells begins about
four days following injury and continues for four weeks [17]. TGF-β plays a central
role by activating fibroblasts for the aforementioned collagen production and regu-
lating protease production to allow the proliferation and gradual growth of new skin
[22]. The remodeling stage follows this period of intense epithelialization as MMPs
and other enzymes interact with the fibroblasts to reorganize and reconstruct the
ECM in the new skin. The collagen composition is structurally modified through an
increase in diameter of produced collagen and an intensified presence of cross-linking,
strengthening the wound tissue. As the healing progresses in this stage, the rate of
collagen synthesis eventually balances with that of collagen destruction, allowing the
skin to reach equilibrium once again. The skin begins to become less cellular as the
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excess cells recruited for healing undergo apoptosis. Even so, remodeling of the scar
tissue may continue for many years to promote the structural integrity of the skin
[43].
In a chronic wound, such as a diabetic foot ulcer, healing may not occur in the
systematic manner seen in acute wounds; instead, these wounds often linger in the
inflammatory stage of the healing process. The prolonged presence of neutrophils
and macrophages in a chronic wound may contribute to the increased length of the
inflammatory stage [25]. In this case, neutrophils produce abnormally high levels of
MMP, leading to the break down of ECM at a faster rate than the fibroblasts are
able to construct it. The resulting imbalance between proliferation and degradation
plays a major role in the length of the inflammatory phase and late epithelialization
in chronic wounds.
The careful regulation of MMPs, especially in chronic wounds, is critical to the
nature of wound healing [19]. TIMPs must precisely inhibit MMPs to maintain the
production of the ECM at a functional rate, or else risk excessive proteolysis. This
role of the TIMPs is therefore extremely important in imbalanced chronic wounds,
marking the ratio of MMPs-to-TIMPs as vital to the control of the breakdown of
ECM during effective wound healing [25]. Muller et al. (2008) showed that the initial
ratio of MMP-1-to-TIMP-1 is considered a useful predictive measure of the healing
response. Higher levels of MMP-1 early in the wound-healing process favor good
healing and may play a part in the successful progression of the proliferation stage.
Accordingly, a high level of TIMP-1 later during the healing process indicates the
regulation of the MMPs, representing the prevention of excessive breakdown of the
ECM.
In Muller et al. (2008), the authors measured the levels of select isoforms of MMPs
and TIMPs (specifically, MMP-1, -2, -8, and -9 and TIMP-1) from wound fluid. In
order to identify which of these key proteins contributes significantly to a positive
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healing outcome, the authors divided the patients into groups, identified as “good
healers” and “bad healers,” and compared the average healing responses of the two
groups. A large prospective trial study (Sheehan et al. 2003) showed that the percent
change in wound surface area over a 4-week period is indicative of how long-term
healing will occur. Specifically, the study found the mean percentage reduction in
wound area at four weeks for those who healed within 12 weeks was 82%. Therefore,
Muller classified “good healers” by a reduction of at least 82% in initial wound sur-
face area at 4 weeks, and “poor healers” by a reduction in wound surface area of less
than 82% at 4 weeks. The authors concluded that the ratio of MMP-1-to-TIMP-1, as
opposed to just taking either measurement separately, measured at Weeks 0 and 2,
best correlate and predict a positive healing response at Week 4 and complete healing
response at Week 12. Muller hypothesizes an up-regulation of MMP-1 completes the
proliferative phase of healing as it has also been shown to be a key mediator for ker-
atinocyte migration re-epithelialization of the epidermal layer [28, 36]. Furthermore,
Muller suggests that an increase in TIMP-1 between Weeks 0 and 2 is needed to
regulate MMP-1 levels for successful healing.
In this work, a mathematical model is formulated, which describes the interactions
of MMP-1 and their inhibitors, specifically TIMP-1, and their effect on the healing
response, measured by ECM levels. Mathematical models have been formulated to
describe and analyze specific aspects of the wound-healing process (for review, see
[35] and [10]). While many of these models use differential equations, which often
include protein-cell, protein-protein, or cell-cell interactions, they are often qualitative
in nature due to the sparseness of temporal data [10]. Although these models can
still be used to analyze a physiological process or a treatment response, a model that
uses data to measures parameters is, in general, preferable. Ideally, data from a single
patient can be used to quantify the model and then the model can be used to predict
a future response and individualize treatment. Yet, even averaged patient data can
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still be useful in trying to make model predictions. Averaged data from Muller et
al. (2008) is used to parameterize our model. After the model has been curve fit
to data, the model is then analyzed through steady-state and multiple sensitivity
analyses. Sensitivity analysis can help to elucidate which parameters may play a
key role in determining or altering the model behavior. Given the range of realistic
potential parameter values depending on whether an individual mounts a good or
poor healing response, it is important to consider both local and global sensitivity
approaches [20].
2.2 Materials and methods
2.2.1 Clinical data
Experimental data for modeling were taken from Muller et al. (2008), a 12-week
prospective trial study that monitored and treated sixteen patients with Type-2 di-
abetes and neuropathy, ranging in age from 47 to 84, with a chronic diabetic foot
ulcer rated 1 to 3, stage A according to the University of Texas Wound Classification.
At each visit (weeks 0, 1, 2, 4, 8, and 12), the percent of wound closure and con-
centrations of specific isoforms of MMPs (MMP-1, -2, -8, and -9) and TIMP-1 were
measured. Proteins were collected in wound fluid using sterile absorbent paper strips
placed on the end of the wound for five minutes. In order to avoid variations in the
amount of collected fluid, all proteins were measured as ratios of the concentration of
the particular isoform of the MMP or TIMP (in picograms) to the total number of
proteins (in micrograms). Wound area was measured by examining numeric photog-
raphy and analytical software. Median data estimated from line graphs in Muller et
al. (2008) is given in Table 1.
In their study, patients were carefully selected and treated in order to minimize
excess protein levels in the data collection. For example, patients with soft tissue
infections in the wound were excluded from the study since bacteria may secrete
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Table 2.1: Patient data collected by Muller et al. (2008). By week 8 7/7 good healers
completely healed, whereas by week 12 3/9 poor healers had not healed [25].
Good Healers Poor Healers
Week
MMP-1 TIMP-1 Wound MMP-1 TIMP-1 Wound
(pg/µg) (pg/µg) Closure (pg/µg) (pg/µg) Closure
0 4.75 3.17 0% 2.6 4.20 0%
1 2.70 4.15 40% 2.23 4.62 5%
2 4.88 6.59 70% 2.27 4.54 30%
4 0.98 3.17 85% 2.23 4.63 52%
8 0.98 1.96 100% 2.73 3.70 80%
12 — — — 5.04 3.78 100%
excess MMPs. Yet, two patients with osteomyelitis were included since osteomyelitis
is not necessarily associated with soft-tissue infection. Wound dressings (as well as
oral antibiotics for patients with osteomyelitis) were also chosen to not interfere with
MMP levels.
To relate our model with healing prediction described in Muller et al. (2008),
we adopt the same “good healers” and “poor healers” categorization. MMP-1 and
TIMP-1 data were nondimensionalized with respect to the TIMP-1 concentration at
inclusion (Week 0). This scaling gives a direct way of identifying the MMP-1 to
TIMP-1 ratio that is critical in wound-healing prediction. ECM levels were taken to
be proportional to wound closure. Nondimensionalized data is given in Table 2.
Table 2.2: Nondimensionalized data for modeling.
Good Healers Poor Healers
Week MMP-1 TIMP-1 ECM MMP-1 TIMP-1 ECM
0 1.50 1.00 0.00 0.62 1.00 0.00
1 0.85 1.31 0.40 0.53 1.10 0.05
2 1.54 2.08 0.70 0.54 1.08 0.30
4 0.31 1.00 0.85 0.53 1.10 0.52
8 0.31 0.62 1.00 0.65 0.88 0.80
12 — — — 1.20 0.90 1.00
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2.2.2 Mathematical Framework
We introduce here a data-driven mechanistic model to follow the evolution of
matrix metalloproteinases (M ), their inhibitors (T ), extracellular matrix (E ), and
fibroblasts (f ) with respect to time to describe their interactions in a healing wound.
A general mathematical model describing the biological processes is the initial value
problem
d~x
dt
= f(t, ~x, ~θ), ~x(0) = ~x0, (2.1)
where f : R1+n+q → Rn, t ∈ R denotes time, ~x ∈ Rn denotes the state vector, ~θ ∈ Rq
denotes the model parameters, and ~x0 is the initial state vector at time t = 0. Model
outputs corresponding to available data are computed as
y = g(t, ~x, ~θ), (2.2)
where g : R1+n+q → Rm and m is the number of output variables. Data for modeling
sampled at times ti are given in a set of data ~Y , with associated model outputs from
Eq. (2.2) in vector ~y. These vectors are represented by:
~Y =
(
Y1(t11), Y1(t12), . . . , Y1(t1k1), . . . , Ym(tm1), Ym(tm2), . . . , Ym(tmkm)
)T
, (2.3)
~y =
(
y1(t11), y1(t12), . . . , y1(t1k1), . . . , ym(tm1), ym(tm2), . . . , ym(tmkm)
)T
, (2.4)
where ~Yl and ~yl are the l’th components of the vectors with length K, or the number
of observations.
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Model Equations
Equation for matrix metalloproteinases (M). We model fibroblast production
of MMP-1 by a Hill function of order α [1]. During the wound-healing process, TIMPs
bind to MMPs in a one-to-one inhibitor-to-enzyme ratio [4]. This regulatory effect is
modeled by an inhibition term, characterized by a rate constant k4, and is proportional
to MMP and TIMP concentrations. Lastly, we assume that MMPs linearly decay with
rate constant k3. With these assumptions, we have:
dM
dt
=
k1M
αf
kα2 +M
α︸ ︷︷ ︸
Production
− k3M︸︷︷︸
Decay
− k4MT︸ ︷︷ ︸
Inhibition
. (2.5)
Equation for tissue inhibitors of matrix metalloproteinases (T). We assume
that fibroblasts produce TIMP-1 in the presence of MMPs [27]. We also represent
TIMP production by a Hill function of order β [1]. Since the binding of TIMPs to
MMPs also reduces TIMP activity, the inhibition term in equation (2.5) is also used
to model the inhibition of TIMPs, with the same rate constant k4. The decay of this
protein is assumed to be linear with rate constant k7. We thus have:
dT
dt
=
k5T
βfM
kβ6 + T
β︸ ︷︷ ︸
Production
− k7T︸︷︷︸
Decay
− k4MT︸ ︷︷ ︸
Inhibition
. (2.6)
Equation for extracellular matrix (E). Collagen, the main component of ECM,
is synthesized by fibroblasts [17]. We model production of ECM with a rate constant
k8 and a carrying capacity of E0 [17, 22]. Since MMP activity degrades ECM [19, 36],
we assume this process occurs with rate constant k9. Taking natural decay of ECM
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to occur linearly with rate constant k10, we obtain:
dE
dt
= k8f
(
1− E
E0
)
︸ ︷︷ ︸
Production
− k9ME︸ ︷︷ ︸
Degradation
− k10E︸︷︷︸
Decay
. (2.7)
Equation for fibroblasts (f). Although there is no data for fibroblasts, it is in-
cluded in the model because we need a cell type to produce the proteins MMP-1,
TIMP-1, and ECM. In order to do so, we model the proliferation of fibroblasts with
a standard logistic growth term with carrying capacity f0. We also assume cells die
at constant rate k12 proportional to cell count. We thus have:
df
dt
= k11f
(
1− f
f0
)
︸ ︷︷ ︸
Production
− k12f︸︷︷︸
Death
. (2.8)
Although the proposed model for fibroblasts is simple due to the absence of cell data,
we chose this form of the equation because it still allows us to reliably model the data.
While a closed-form solution can be found for this equation, we leave the fibroblast
equation in differential-equation form for subsequent work.
Nondimensionalization
To nondimensionalize equations (2.5)− (2.8), we scale the MMP-1 and TIMP-1 levels
by the initial concentration of TIMP-1 at Week 0 (Tinit), the ECM and fibroblasts by
their carrying capacities E0 and f0, respectively, and time by t0 = 1 day. Under these
conditions, nondimensionalized variables and parameters (labeled with a *) are:
{M∗, T ∗, E∗, f ∗, t∗} =
{
M
Tinit
,
T
Tinit
,
E
E0
,
f
f0
,
t
t0
}
, (2.9)
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{k∗1, k∗2, k∗3, k∗4, k∗5, k∗6} =
{
k1f0t0
Tinit
,
k2
Tinit
, k3t0, k4t0Tinit, k5f0t0,
k6
Tinit
}
,
{k∗7, k∗8, k∗9, k∗10, k∗11, k∗12} =
{
k7t0,
k8f0t0
E0
, k9t0Tinit, k10t0, k11t0, k12t0
}
.
(2.10)
Rewriting our model in terms of the dimensionless variables and parameters (and
removing * for simplicity) gives the following system of differential equations:
dM
dt
=
k1M
αf
kα2 +M
α
− k3M − k4MT, (2.11)
dT
dt
=
k5T
βfM
kβ6 + T
β
− k7T − k4MT, (2.12)
dE
dt
= k8f(1− E)− k9ME − k10E, (2.13)
df
dt
= k11f(1− f)− k12f, (2.14)
together with the initial conditions
M(0) =
Minit
Tinit
, T (0) = 1, E(0) = 0, f(0) = fi. (2.15)
In terms of equations (2.1) and (2.2), the state vector is ~x = (M∗, T ∗, E∗, f ∗)
with length n = 4, and the model output function gives (M∗, T ∗, E∗) with length
m = 3. The initial state vector is ~x0 = (Minit/Tinit, 1, 0, fi). Our model has q = 12
parameters, given by
θ = (k∗1, k
∗
2, k
∗
3, k
∗
4, k
∗
5, k
∗
6, k
∗
7, k
∗
8, k
∗
9, k
∗
10, k
∗
11, k
∗
12)
T . (2.16)
Nondimensionalized equations (2.11) – (2.14) and initial conditions (2.15) were chosen
as the simplest system of equations that captures the key fundamental mechanisms
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of healing in diabetic foot ulcers.
2.2.3 Parameter Estimation
Curve fitting each state variable to the data was done by minimizing the least-
squares residuals between collected data and model output (Eq. (2.3) and (2.4)).
Matlab was used to solve the nonlinear optimization problem of minimizing the func-
tional (J -value)
J =
K∑
l=1
|~yl − ~Yl|2. (2.17)
Values for ~yl were approximated by the stiff differential equation solver ode15s with an
absolute and relative error tolerance of O(10−6). Matlab’s GlobalSearch and fmincon
were used to find the global minimum of (2.17). GlobalSearch uses a scatter search
algorithm to generate a programmed number of trial parameters subject to given
optimizing constraints, and fmincon rejects those that were unlikely to improve the
best local minimum found so far [23]. To keep parameters within a numerically
feasible range, GlobalSearch searched for parameter values between 0 and 200. The
sets of parameters corresponding to the smallest J -values for good healers and poor
healers were recorded, and graphs of the curve-fits were used to evaluate sources of
error and compare good and poor healers.
2.2.4 Steady-State Analysis
Analyzing the mathematical model independently of parameter values or patient
category is important in interpreting the biology of the system of equations, as the
results can then be used to draw conclusions for patients not included in the parameter
estimation. A steady-state analysis was conducted to find the levels of the proteins
and cells as t → ∞. We solved for the model equilibria, and stability was assessed
by computing the Jacobian matrix. When the steady-state equations could not be
solved algebraically, steady-states and their stabilities were identified by intersections
CHAPTER 2. MMP–1/TIMP–1 MODEL 17
of the nullclines of the differential equations.
2.2.5 Global sensitivity analysis
The existence of multiple steady-states implies that the convergence to an end
state is dependent upon the values of specific parameters. A small change in a pa-
rameter value could be the difference between convergence to a “healed” state or a
“non-healed” state. Sensitivity analyses were conducted to determine how sensitive
the system of equations is to changes in parameter value(s). A parameter whose
change has a large impact on the model output is said to be “sensitive” and a pa-
rameter whose change has a negligible impact on the model output is said to be
“insensitive.” A “global” sensitivity analysis is independent of parameter estimates
and covers a wide range of the parameter space, while a “local” analysis examines
a small neighborhood of a particular point in the parameter space. Both global and
local analyses were conducted in this work.
A global analysis was conducted using a Latin Hypercube Sampling (LHS) scheme
combined with Partial Rank Correlation Coefficient (PRCC) analysis. LHS, a type
of stratified Monte Carlo sampling scheme, assigns a probability distribution to each
parameter, partitions the intervals in the distribution into a given number of equiprob-
able regions, and samples each of the intervals without replacement. The sampling
provides a global analysis of the parameter space by treating each model parameter
as a random variable [13, 24, 37].
Partial rank correlation measures the strength of the relationship between the
output of each state function and the model parameters [15, 20]. Standard correlation
measures the strength of a linear association between variables (e.g. a parameter and
output). The PRCC value measures the correlation of the ranked ordering of the
variable values rather than the variable values themselves [5]. The advantage of the
PRCC over traditional correlation measures is that the rank transformation allows
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us to consider non-linear, monotonic relationships [12, 14].
Partial rank correlation coefficients provide a measure of the strength of the sta-
tistical relationship between each parameter and state function, while discounting the
effects of the other parameters on the outputs. PRCC values range from −1 to 1,
with the magnitude indicating the sensitivity of the state function to the parameter
uncertainty and the sign indicating whether the correlation is positive or negative.
The p-value of the PRCC indicates the significance of the value. A state variable is
sensitive to a parameter if the absolute value of the PRCC is greater than 0.5 and
the corresponding p-value is less than 0.05.
If each observation in Eq. (2.4) (i.e. each time point for each observed state
variable) is monotonic (described below) with respect to each input, the algorithm
for the LHS/PRCC method is described as follows:
1. Assign a probability density function to each model input of interest. In this
work, we are concerned with parameter sensitivity, so for the i ’th parameter,
assign a probability density function on the interval [li, ui], where li and ui are
the lower and upper bounds in the parameter estimation (1 ≤ i ≤ q).
2. Partition each [li, ui] into N equally probable subintervals. As in [3, 24], we
require N > 4
3
q.
3. For the i ’th parameter, randomly sample the subintervals without replacement.
Then sample a random number from each subinterval and enter randomized
list into the ith column of the N × q matrix L. Each row of matrix L can be
considered to be a set of parameter values.
4. Compute the model outputs for all N sets of parameter values at a given time
point.
5. Rank the N entries in each column of L from smallest to largest. Separately,
for each state variable, rank the N model outputs from smallest to largest.
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6. Perform a multiple linear regression for each set of ranked parameters and each
ranked output in relation to all other parameter rankings.
7. To calculate the PRCC for a parameter and output combination, plot the resid-
uals from the corresponding regressions and compute the Pearson linear corre-
lation coefficient, our PRCC value, and associated p-value for the correlation of
the residuals [20].
8. Repeat steps 3 – 7 100 times. Let PRCCi,j,k and pi,j,k be the PRCC value and
p-value of the i ’th parameter with respect to the j ’th state variable in the k ’th
PRCC calculation (1 ≤ i ≤ q, 1 ≤ j ≤ n, 1 ≤ k ≤ 100).
9. Compute the sensitivity Si,j of the i ’th parameter with respect to the j ’th state
variable using a weighted norm:
Si,j =
√√√√ 100∑
k=1
(PRCCi,j,k(1− pi,j,k))2. (2.18)
10. Compute the total sensitivity Si of the i ’th parameter. Let I be the set of
indices of the states we are interested in using to determine sensitivity. Then
Si =
√∑
j∈I
S2i,j. (2.19)
To verify monotonicity of the state variables with respect to the m’th parameter, we
constructed an N × q matrix M = (Mij), where N is the number of simulations (Step
2) and Mij is the baseline value for the j ’th parameter. We replaced the m’th column
of this matrix with the m’th column of a Latin Hypercube Matrix. Next, we generated
model outputs at a fixed time point using each of the N sets of parameters. Plotting
the output against the corresponding values for the m’th parameter, we visually
observed if the relationship was monotonic. If a state function was not monotonic
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with respect to a parameter over the entire parameter space, we conducted the PRCC
analysis over the intervals for which the relationship was monotonic.
2.2.6 Local sensitivity analyses
Classical sensitivity analysis
A classical sensitivity analysis described in [8] and [9] quantifies and ranks the
sensitivities of individual model parameters with respect to other parameters. The
sensitivity of the model output y with respect to a single parameter θi can be repre-
sented by the columns of a sensitivity matrix,
~S =
∂y
∂θ
=

∂y1/∂θ1(t11) · · · ∂y1/∂θq(t11)
...
...
...
∂y1/∂θ1(t1k1) · · · ∂y1/∂θq(t1k1)
...
...
...
∂ym/∂θ1(tm1) · · · ∂ym/∂θq(tm1)
...
...
...
∂ym/∂θ1(tmkm) · · · ∂ym/∂θq(tmkm)

. (2.20)
Methods used in the sensitivity analysis are more efficient if parameter values are the
same order of magnitude [29], so we scaled the parameters by the natural logarithm,
i.e. θ˜ = ln θ. Relative sensitivities were computed by multiplying each element by a
nondimensionalizing factor
S˜ =
∂y
∂θ˜
1
y
. (2.21)
Partial derivatives were computed using forward finite-difference approximations
∂yk
∂θj
≈ yk(t, x, θ˜ + h~ej)− yk(t, x, θ˜)
h
,
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where ~ej is the j’th standard basis vector in Rq. A scaled 2-norm is used to evaluate
the total sensitivity, Sj, of the j ’th parameter
Sj =
(
1
K
K∑
i=1
S2i,j
)1/2
.
To separate sensitive and insensitive parameters we consider the computational ac-
curacy of finite-difference approximation and hence the sensitivity matrix. Following
Pope et al. (2009) and Olufsen et al. (2013), the error in computing the sensitivity
matrix is one order of magnitude greater than the square root of the absolute error
tolerance of the ode solver, or O(10−2). Parameters with sensitivity values greater
than 10−2 were classified as “sensitive.”
Although sensitivity analyses employing analytical or automatic differentiation
(see [7] and [38]) are more accurate, forward finite difference approximation using
scaled parameter values is computationally efficient for a complex system of equations.
SVD-QR subset selection
While the classical sensitivity analysis provides a way of identifying the sensitivity
of parameters individually, it is also advantageous to find a subset of parameters
sensitive as a group. The subset selection uses the singular value decomposition
to determine the numerical rank ρ of the sensitivity matrix. The rank is used to
determine the number of parameters in the subset. The QR factorization of the
right matrix of eigenvectors after column pivoting determines which ρ parameters are
sensitive as a group. As stated in the classical sensitivity analysis section, the errors of
the sensitivities are O(10−2), so the smallest allowable singular value in determining
the rank was set as 10−2.
The SVD-QR algorithm for subset selection described in Olufsen et al. (2013) is
as follows:
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1. Using parameter estimates in ~θ and the sensitivity matrix (2.21), calculate the
singular value decomposition, S ′ = UΣV T .
2. Calculate ρ, the rank of the scaled sensitivity matrix. Here, ρ is the number of
singular values (extracted from Σ) greater than 10−2.
3. Partition V into V = [Vρ Vn−ρ].
4. Determine a permutation matrix P such that V Tρ P = QR, where R is an upper
triangular matrix with diagonal elements in decreasing order of magnitude. This
is done with column pivoting after the maximal element for V Tρ [11].
5. Use P to re-order the vector of parameters θ as θ0 = P
T θ.
6. The first ρ elements of the re-ordered vector of parameters are sensitive as a
group.
2.2.7 Local-to-global analysis
To compare the results of the local and global sensitivity analyses, we developed a
“local-to-global” analysis to study the sensitivities of the parameters as the parameter
space in the LHS/PRCC analysis shifts from local to global. Given the parameter
estimates in vector ~θ = (θ1, . . . , θq), we construct 100 spaces in two ways:
• Boundary method : the nth parameter space is given by the set of all points
P (n) = (θ
(n)
1 , . . . , θ
(n)
q ) whose coordinates satisfy the inequalities θi − n ∗ (θi −
li)/100 ≤ θ(n)i ≤ θi + n ∗ (ui − θi)/100, where li and ui are the lower and upper
bounds for θi in the parameter estimation.
• Percentage method : the nth parameter space is given by the set of all points
P (n) = (θ
(n)
1 , . . . , θ
(n)
q ) whose coordinates satisfy the inequalities θi∗(1−n/100) ≤
θ
(n)
i ≤ θi ∗ (1 + n/100).
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The first method increases the bounds of the parameter spaces linearly until the
global bounds are reached, while the second method constructs intervals around the
parameter estimates that grow from 1% to 100% of the estimate in each direction.
We conduct an LHS/PRCC analysis for each parameter space and plot the total
sensitivities and sensitivity rankings of each parameter over the 100 iterations. We
quantify the magnitude of the change in sensitivity of the ith parameter by
∆Si = max
1≤n≤100
Si,n − min
1≤n≤100
Si,n,
where Si,n is the total sensitivity of the ith parameter in the nth parameter space
computed using Eqs. (2.18) and (2.19). The changes in sensitivity are normalized by
the smallest change for all parameters. That is,
∆S∗i =
∆Si
min1≤i≤q ∆Si
.
The relative changes, together with the sensitivity plots, were used to directly compare
the results of the two types of sensitivity analyses done in this work and to determine
parameters whose sensitivity varied the most as the parameter space expanded from
local to global.
2.3 Results
Using the numerical methods and curve fitting procedures described in the meth-
ods section, we found optimal parameter values for the data from each patient group.
Because there is no data for fibroblasts, an initial condition for the ODE solver was
found through simulations. Different initial values for f(0) = fi were tested, and
0.1 most consistently gave the best J -value. Similarly, we determined Hill function
orders in the MMP and TIMP equations to be α = β = 3. The parameter sets cor-
responding to the minimized least-squares residual for both patient groups are given
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Table 2.3: Nondimensionalized parameter estimates from curve fitting. The J -values
indicate there is very good agreement between the model and data for the good healers
and excellent agreement for the poor healers. Graphs in Figures 2.1 and 2.2 illustrate
the agreement as well.
Parameter Good Healers Poor Healers
k1 32.715 1.597
k2 3.613 0.834
k3 0.042 0.206
k4 0.652 0.009
k5 4.724 39.861
k6 0.027 18.973
k7 2.001 0.003
k8 1.582 0.689
k9 0.365 0.002
k10 0.013 0.002
k11 3.499 3.025
k12 0.067 1.837
J 0.5064 0.0525
in Table 2.3, with corresponding plots of the model fitted to the data in Figures 2.1
and 2.2.
The best sets of parameters for both good healers and poor healers were found
when GlobalSearch routine selected 600 sets of values for ~θ. Simulations run for more
than 600 trial points generated parameters that corresponded to the same model
outputs. The parameter sets generated by 600 trial points were selected because they
contained the least number of parameters close to the boundary of the parameter
space and were more likely to be biologically feasible.
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Figure 2.1: Graphs of good healers are of MMP-1 (top left), TIMP-1 (top right),
ECM (bottom left), and fibroblasts (bottom right). The shaded circles are the nondi-
mensionalized 50th percentile data from Table 2.2, with the error bars representing
the 25th and 75th percentile data collected by Muller et al. (2008)
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Figure 2.2: Graphs of poor healers are of MMP-1 (top left), TIMP-1 (top right),
ECM (bottom left), and fibroblasts (bottom right). The shaded circles are the nondi-
mensionalized 50th percentile data from Table 2.2, with the error bars representing
the 25th and 75th percentile data collected by Muller et al. (2008)
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2.3.1 Steady-state Analysis
Equations (2.11) – (2.14) were first rewritten to be functions of the states present
in the equations,
dM
dt
= p(M,T, f), (2.22)
dT
dt
= q(M,T, f), (2.23)
dE
dt
= r(M,E, f), (2.24)
df
dt
= s(f), (2.25)
The steady-states, denoted by ~x = (M,T ,E, f), are the solutions to equations (2.22)
– (2.25) when the derivatives are set to 0. Only nonnegative solutions were considered.
The stability of each steady-state was determined by computing the eigenvalues of
the Jacobian matrix (2.26) evaluated at the steady-state.
J1(M,T ,E, f) =

∂p
∂M
∂p
∂T
∂p
∂E
∂p
∂f
∂q
∂M
∂q
∂T
∂q
∂E
∂q
∂f
∂r
∂M
∂r
∂T
∂r
∂E
∂r
∂f
∂s
∂M
∂s
∂T
∂s
∂E
∂s
∂f

. (2.26)
Evaluating (2.26) results in a matrix whose only nonzero element in the third column
is ∂r/∂E and only nonzero element in the fourth row is ∂s/∂f . Therefore the eigen-
values of (2.26) are the those two partial derivatives and the eigenvalues of the 2× 2
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block matrix in the upper left-hand corner,
J2(M,T ,E, f) =
 ∂p∂M ∂p∂T
∂q
∂M
∂q
∂T

=

−k3 − k4T + 3k1k
3
2fM
2
(k32 +M
3
)2
−k4M
−k4T + k5fT
3
k36 + T
3 −k7 − k4M +
3k5k
3
6fMT
2
(k36 + T
3
)2
 .
(2.27)
From equations (2.24) and (2.25),
E =
fk8
k10 + fk8 + k9M
, (2.28)
f = 0 or
k11 − k12
k11
. (2.29)
We note that for any M and f ,
∂r
∂E
= −k10 − fk8 − k9M < 0. (2.30)
The derivative
∂s
∂f
= (1− f)k11 − fk11 − k12 (2.31)
will be looked at in the proceeding cases. Nonzero solutions for M and T cannot be
in found explicitly in terms of model parameters and other states. The general cases
are analyzed for stability, and, if possible, existence.
Case 1: f = 0. Mathematically and biologically, this is the simplest case. The only
steady-state vector ~x with all nonnegative components for this case is (M,T ,E, f) =
(0, 0, 0, 0). The eigenvalues of the Jacobian matrix (2.26) evaluated at this state are
−k3, −k7, −k10, and k11 − k12, so ~x is stable when k11 < k12 (when the growth rate
CHAPTER 2. MMP–1/TIMP–1 MODEL 29
of fibroblasts is less than the death rate).
Case 2: M = 0, f 6= 0. Solving for the other states gives E = (fk8)/(k10 + fk8),
T = 0, and the nonzero f given in (2.29). The eigenvalues of (2.26) evaluated at this
state are −k3,−k7, and the derivatives given in equations (2.30) and (2.31). Plugging
f into (2.31), we see that when k11 > k12, ~x = (0, 0, E, f) is a stable steady-state.
Noting that if k11 < k12 the nonzero f is negative, we conclude that this steady-
state is stable if it exists. Since (2.31) is only dependent on f , the stability of the
steady-state is unaffected by k11 and k12 for all subsequent f 6= 0 cases.
Case 3: M 6= 0, T = 0, f 6= 0. Rewriting (2.22) as a polynomial by plugging in
T = 0 and multiplying by (−k32 −M3)/M ,
ϕ(M) = k3M
3 − fk1M2 + k3k32. (2.32)
With this notation, the positive zeros of ϕ are the M values of the steady-states.
It can be checked that ϕ′(M) = 0 when M = 0 or 2fk1/(3k3). The second root of
ϕ′(M) corresponds to the relative minimum of ϕ(M). Since ϕ(0) > 0, positive roots
exist if and only if the relative minimum is less than or equal to zero.
27k23 · ϕ
(
2fk1
3k3
)
= 27k32k
3
3 − 4f
3
k31. (2.33)
It follows that a steady-state exists only if
27k32k
3
3 ≤ 4f
3
k31. (2.34)
To assess the stability of the steady state(s), assume the condition holds. If ϕ(M) = 0,
then by Eq. (2.32),
k32 +M
3
=
k1fM
2
k3
. (2.35)
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The eigenvalues of (2.26) evaluated at ~x = (M, 0, E, f) are the diagonal entries. The
entries in the second, third, and fourth rows are negative. Substituting the equality
in Eq. (2.35) and evaluating the eigenvalue λ gives
λ = k3
(
2fk1 − 3k3M
fk1
)
=
−k3 · ϕ′(M)
fk1M
(2.36)
The expression is negative if and only if ϕ′(M) > 0. It follows that if the condition
in Eq. (2.34) is an equality, then the steady state is unstable. In the case where the
condition is a strict inequality, the larger of the two roots is stable.
Case 4: M 6= 0, T 6= 0, f 6= 0 For this case, M and T cannot be easily found
algebraically. Necessary conditions for existence of the nullclines of (2.22) and (2.23)
in the 1st quadrant are established to ensure that intersections can occur when M > 0
and T > 0. Solving for T in p/M = 0 and M in q/T = 0 give the nullclines of (2.22)
and (2.23) respectively,
T = g(M) =
−k32k3 + fk1M2 − k3M3
k4(k32 +M
3)
(2.37)
M = h(T ) =
k7(k
3
6 + T
3)
−k4k36 + fk5T 2 − k4T 3
. (2.38)
The y-intercept of g(M) is −k3
k4
< 0 and lim
M→∞
g(M) =
−k3
k4
< 0. Because g(M) is
a continuous function over the interval [0,∞) the relative maximum in this interval
must be greater than 0 for existence in the 1st quadrant. The only relative maximum
value in the domain [0,∞) is 22/3fk1−3k2k3
3k2k4
. Thus, the condition for the existence of
the nullcline (2.37) in the 1st quadrant is
22/3fk1 > 3k2k3. (2.39)
CHAPTER 2. MMP–1/TIMP–1 MODEL 31
The y-intercept of h(T ) is −k7
k4
< 0 and limT→∞ h(T ) = −k7k4 < 0. The function is
continuous and negative over the domain T ∈ [0,∞) unless there is a discontinuity of
the second kind resulting from a zero in the denominator. By imposing a condition
such that there are exactly two zeros in the denominator in [0,∞), at least one part
of the graph will be in the 1st quadrant. Let
φ(T ) = −k4k36 + fk5T 2 − k4T 3. (2.40)
Routine computation shows that φ′(T ) = 0 when T = 0 or 2fk5/(3k4). Noting that
φ(0) < 0 and that φ has positive roots if and only if the relative maximum of φ(T ) is
greater than 0,
27k24 · φ(
2fk5
3k4
) = 4f
3
k35 − 27k34k36. (2.41)
It follows that h(T ) has discontinuities if and only if
4f
3
k35 > 27k
3
4k
3
6. (2.42)
Conditions (2.39) and (2.42) are necessary conditions for the nullclines’ existence in
the 1st quadrant and are not sufficient conditions for the existence of the steady-
state(s). To check for stability, we note that the real parts of the eigenvalues of a 2x2
matrix are negative if and only if the trace is negative and determinant is positive.
The trace and determinant of matrix (2.27) are
tr(J2) =
k4M
2g′(M)− k7Th′(T )
M
, (2.43)
det(J2) = k4k7(g
′(M) · h′(T ) + T ). (2.44)
CHAPTER 2. MMP–1/TIMP–1 MODEL 32
Setting the trace to be less than 0 and the determinant to be greater than 0, two
conditions for stability are found:
k7Th
′(T ) > k4M2g′(M), (2.45)
g′(M) · h′(T ) > −T. (2.46)
2.3.2 Sensitivity analysis
Global sensitivity analysis
The Latin Hypercube Sampling method combined with Partial Rank Correlation
provided an efficient way to analyze parameter uncertainty over the entire parameter
space. Following Marino et al. (2008), we chose to assign a uniform distribution to
each of the twelve parameters in the LHS scheme and partitioned each interval into
N = 30 equiprobable subintervals [20]. We verified the monotonicity of our model
with respect to the parameters at time points associated with the data collection by
Muller. The baseline values were chosen to be the parameter estimates for good and
poor healers. Sample monotonicity plots are shown in Figure 2.3.
The sensitivities of each parameter with respect to each state variable and the
total sensitivities of the parameters over every state and only the observed states are
given in Table 2.4, with ranked total sensitivities in Table 2.5. Examples of PRCC
plots used to calculate the PRCC values and sensitivities are shown in Figures 2.4 –
2.7. To classify parameters as sensitive or insensitive for a given state, we define a
lower bound for parameter sensitivity, S1. For one LHS matrix, a state variable is
sensitive to a parameter if the absolute value of the PRCC is greater than 0.5 and the
corresponding p-value is less than 0.05. Using these bounds and Eq. (2.18), a lower
bound over 100 LHS matrices is
S1 =
√
100(0.5(1− 0.05))2 = 4.75.
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Parameters with Si,j > 4.75 were said to be “significantly sensitive” to state j. By
equation (2.19), if there are η many states of interest, the lower bound for total
sensitivity is
Sη =
√
η · S1.
Using this classification, the sensitive parameters/state combinations are are: k3(M),
k7(T ), k10(E), k11(E, f), and k12(E, f). It should be noted that every parameter
associated with a decay term is sensitive. The other three pairings, k11(E), k11(f),
and k12(E), are associated with the growth and decay of fibroblasts and their effect
on ECM proliferation.
Table 2.4: Global sensitivity analysis results. The first four columns are the sensi-
tivities of individual states to each parameter. Bolded sensitivity values are greater
than 4.75, indicating that the state variable is significantly sensitive to the parameter.
The last two columns are the total sensitivities taken over every state and over the
observed states.
Sensitivity Total
M T E F SM,T,E,f SM,T,E
k1 2.203 2.120 1.949 2.168 4.224 3.625
k2 2.107 2.217 1.939 1.971 4.124 3.622
k3 8.392 1.890 2.058 2.271 9.132 8.845
k4 1.880 2.351 2.103 1.813 4.096 3.672
k5 1.865 2.029 2.167 1.761 3.924 3.506
k6 2.102 1.839 1.999 2.205 4.082 3.435
k7 2.445 8.673 1.924 1.938 9.416 9.215
k8 1.998 2.345 4.120 1.542 5.370 5.144
k9 2.129 2.046 2.137 2.132 4.222 3.645
k10 1.995 2.024 5.422 1.669 6.345 6.122
k11 2.318 1.877 8.313 9.021 12.624 8.832
k12 2.174 1.811 8.615 9.363 13.033 9.068
Local sensitivity analysis
Using the parameter estimates for good healers and poor healers, the classical
sensitivity analysis assigned a sensitivity value to each parameter and ranked them
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Figure 2.3: Monotonicity plots for k11 at t = 4. Parameter estimates for the poor
healers were used as baseline values
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Figure 2.4: PRCC Plots for M . Plots of residuals for the multiple linear regression of
ranked model output M with respect to all parameter rankings against the residuals
for the multiple linear regression of the parameter of interest rankings with respect to
all parameter rankings. PRCC and p-values are calculated from the linear regressions
of these plots. The strong correlation in the plot for k3 shows that M is significantly
sensitive to the parameter.
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Figure 2.5: PRCC Plots for T . Plots of residuals for the multiple linear regression
of ranked model output T with respect to all parameter rankings versus residuals for
the multiple linear regression of the parameter of interest rankings with respect to all
parameter rankings. State variable T is significantly sensitive to parameter k7
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Figure 2.6: PRCC Plots for E. Plots of residuals for the multiple linear regression
of ranked model output E with respect to all parameter rankings versus residuals for
the multiple linear regression of the parameter of interest rankings with respect to all
parameter rankings. PRCC and p-values are calculated from the linear regressions of
these plots. State variable E is significantly sensitive to parameters k10, k11, and k12
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Table 2.5: Ranked total sensitivity values computed over observed states. Parameters
classified as significantly sensitive to the model (Si > S3 = 8.23) are bolded.
Param SM,T,E
k7 9.215
k12 9.068
k3 8.845
k11 8.832
k10 6.122
k8 5.144
k4 3.672
k9 3.645
k1 3.625
k2 3.622
k5 3.506
k6 3.435
from most sensitive to least sensitive (Table 2.6). The subset selection identified
parameters that were sensitive as a group. The nine parameters selected in the good
healer model were k1, k2, k3, k4, k5, k7, k8, k9, and k11, and the seven parameters
selected in the poor healer model were k1, k2, k3, k4, k8, k11, and k12.
It should be noted that the local sensitivity analyses are dependent on the baseline
parameter values. Conducting the analyses using a different point in the parameter
space could yield different results. For this reason we chose to conduct the analyses
after finding the optimal parameter estimates. Setting a lower bound for sensitivity
in the classical sensitivity analysis and smallest allowable singular value in the subset
selection reduces any error associated with the choice of baseline parameters.
Local-to-global analysis
Using the boundary and percentage parameter space constructions with good and
poor healer parameter estimates, we conducted an LHS/PRCC analysis on each pa-
rameter space. Matlab experienced numerical problems in the LHS/PRCC analysis
for small parameter spaces. For this reason, we chose to discard the results from the
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Figure 2.7: PRCC Plots for f . Plots of residuals for the multiple linear regression
of ranked model output f with respect to all parameter rankings versus residuals for
the multiple linear regression of the parameter of interest rankings with respect to all
parameter rankings. PRCC and p-values are calculated from the linear regressions of
these plots. State variable f is significantly sensitive to parameters k11 and k12
Table 2.6: Classical sensitivity analysis results. The column for the good healer
subgroup includes the sensitivities for each parameter ranked from most sensitive to
least sensitive, and the column for the poor healers includes the sensitivity value and
ranking in the order of the good healers’ rankings for side-by-side comparison. Bolded
sensitivities indicate a sensitive parameter.
Parameter
Sensitivity Rank Sensitivity Rank
Good Healers Poor Healers
k1 11.983 1 2.700 5
k2 10.622 2 6.633 1
k4 4.984 3 0.122 7
k7 4.716 4 0.010 9
k5 4.712 5 0.005 10
k11 0.768 6 4.864 2
k3 0.471 7 2.948 4
k8 0.248 8 0.387 6
k9 0.080 9 0.002 12
k12 0.034 10 4.641 3
k10 0.004 11 0.002 11
k6 0.001 12 0.015 8
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first four parameter spaces in each construction. However, we note that in the small-
est regions of the percentage method (5%), we found the same sensitive parameters
for both good and poor healers as in the local sensitivity analysis. In particular, k10,
k4, and k2 were all found to be sensitive at these smallest regions, even though they
were insensitive in the larger, more global parameter spaces. Normalized sensitivity
changes are given in Table 2.7, with plots of sensitivities over each parameter space
in Figures 2.8 – 2.11.
Table 2.7: Normalized changes in sensitivities for both patient categories and param-
eter space constructions.
Param
∆S∗, Boundary Method ∆S∗, Percentage Method
Good Healers Poor Healers Good Healers Poor Healers
k1 1.887 2.170 2.088 6.253
k2 1.593 1.773 1.875 8.083
k3 5.998 7.035 4.268 4.204
k4 15.447 18.983 6.150 1.566
k5 2.077 2.269 6.923 1.286
k6 1.696 2.389 1.254 3.140
k7 6.309 7.688 7.811 1.799
k8 2.944 4.237 3.788 1.483
k9 1.683 2.109 4.996 1.000
k10 3.256 2.823 1.996 1.020
k11 2.566 1.299 6.546 6.380
k12 1.000 1.000 1.000 6.762
2.4 Discussion
This work has used patient data to quantify and analyze a mathematical model
for the interactions of matrix metalloproteinases and their inhibitors in a wound.
A steady-state analysis and three types of sensitivity analyses analyzed the effects
of parameters. In particular, the steady-state analysis qualitatively determined how
sensitive the end-states of the model are to parameter(s), and the sensitivity anal-
yses distinguished sensitive parameters from insensitive parameters. Understanding
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Figure 2.8: Parameter sensitivities in the good healer model using the boundary
method. Only parameters with ∆S∗i > 2.3 (the median) are shown. Parameter k4
experiences largest decrease in sensitivity, indicating it is sensitive in small neighbor-
hoods around the parameter estimates but not in the entire parameter space
Figure 2.9: Parameter sensitivities in the poor healer model using the boundary
method. Only parameters with ∆S∗i > 2.3 are shown. As in the good healer case, k4
experiences the greatest change in sensitivity
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Figure 2.10: Parameter sensitivities in the good healer model using the percentage
method. Only parameters with ∆S∗i > 4.0 are shown
Figure 2.11: Parameter sensitivities in the poor healer model using the percentage
method. Only parameters with ∆S∗i > 2.4 are shown. Notably, k6 increases in
sensitivity as the parameter space increases in breadth
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the parameter estimates and comparing the sensitivity analysis techniques provides
insight into the interactions in the wound.
2.4.1 Parameter Estimate Interpretation
Comparisons of estimates for good and poor healers (Table 2.3) highlight differ-
ences and imbalances that may be having the greatest effect on the success of the
healing process. Indeed, there were significant differences between the parameter es-
timates in the good and poor healer cases, with all but one estimate differing by at
least one order of magnitude. This underscores the important regulatory differences
between the two groups.
The production of each enzyme is described by a Hill function, for which there
are two meaningful parameters. The parameters in the numerator (k1, k5) and the
denominator (k2, k6) determine the maximum and half-saturation points for the ac-
tivation/production rate of each enzyme. Overall, we find that for good healers there
is a greater range for increased activation of MMPs than in poor healers. This trend
supports the increased presence of the active enzyme in wounds which heal in a timely
fashion. In contrast, TIMPs have a greater range of activation in poor healers. The
increased activity of TIMPs directly causes increased inhibition of MMPs, contribut-
ing to the prolonged state of inflammation.
The estimates of the natural (non-inhibitory) decay rates also differed between the
patient groups. For poor healers, we see a larger natural decay of MMPs and a very
low rate of TIMP decay; for good healers, we see a larger natural decay of TIMPs.
The effect of TIMPs on ECM degradation through inhibition of MMP activity leads
to considering these parameter estimates in terms of changes in TIMP levels – the
greater the natural decay of the TIMPs, the greater the levels of MMP, and therefore
greater the level of ECM degradation.
In summary, each parameter contributes to an environment that either facilitates
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reconstruction and promotes healing of the wound or prevents it. The regulation and
changes in levels of MMPs and TIMPs tend to be opposite. It is likely that some
biological mediator, such as TGF-β, acts on both enzymes as a regulator and plays
a different role in the modulation of each enzyme.
2.4.2 Steady-state analysis
Although the model end states could not be found analytically in the more general
cases, the simpler ones have biological importance. In Case 1 (~x = (0, 0, 0, 0)), the
end state was stable if and only if k11 < k12. This is expected because the difference in
the growth and death rates will result in the fibroblast levels tending to 0 and hence
protein levels tending to 0. This steady-state corresponds to a completely unhealed,
non-viable tissue condition, with ECM levels at 0. We conclude that the growth rate
of fibroblasts must be strictly greater than the decay rate for any healing activity to
occur. In Case 2 (~x = (0, 0, E, f)), the end state was always stable. Biologically, this
state corresponds to reduced MMP and TIMP activity over time. Wound closure is
also closest to 100% in this case, as M = 0, making E at its maximum in Eq. (2.28).
MMPs are present at low levels except at times of wound healing, so initial activity
followed by low concentrations would indicate a healed wound. We conclude that
this is the healthiest end state. Cases 3 and 4 both represent a less complete healing
response (as M 6= 0, thereby lowering E compared to Case 2).
2.4.3 Comparison of sensitivity analyses
In this paper we presented a comparison of two alternative sensitivity analysis
approaches – a global sensitivity analysis method based on Latin hypercube sampling
and PRCC analysis, as well as a local, derivative-based approach (and the related
subset-selection method). These two complementary approaches revealed distinct
patterns in the sensitive parameters (Tables 2.5, 2.6). Several parameters were sen-
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sitive at one scale but not another—for example k10 was borderline sensitive at the
global level but not at either local point tested, while k2 and k4 were sensitive at both
local points but not globally, and k1 and k5 were only sensitive for the good healer
point in parameter space. In general, the global sensitivity analysis approach primar-
ily recovered parameters coinciding with the poor healer locally sensitive parameters
(k3, k11, k12), recovering only one parameter (k7) from the sensitive group at the good
healer point in parameter space.
To explore these issues further, we generated a series of global sensitivity analyses
at parameter ranges from the full space considered in the original global analysis
to smaller regions centered on each point in the local analysis. This allows us to
mimic the local results using the global method. Indeed, we see a gradual shift in
the parameter sensitivities as they move from the most sensitive parameters found
at each local point to the sensitive parameters across the whole space (Figures 2.8 –
2.11).
The good and poor healer models showed very similar sensitivity patterns with
the boundary method. This is expected for the larger parameter spaces because the
spaces are nearly identical. Parameter k4, the rate of MMP-TIMP inhibition, shows
the greatest change in sensitivity. A discussion of k4 is given below. We also note that
k7 and k3, the decay rates of TIMP and MMP, respectively, are the most sensitive
parameters in every constructed parameter space. All other parameters sensitivities
are independent of the parameter space and are hence not affected by the magnitude
of parameter uncertainty in the LHS algorithm.
Unlike in the boundary method, the percentage method retains some of the local
behavior even at the most global range of parameter space. For this reason, we use
the percentage method to investigate the behavior of parameter sensitivities in small
parameter spaces representing the local physiological ranges. In general, for both
good healers and poor healers, the results from the LHS/PRCC method applied to
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the 5% parameter space agree with the sensitivity rankings obtained from the classical
sensitivity analysis. With the exception of k6 for poor healers, the parameters which
are significantly sensitive in a local parameter space decrease in sensitivity as the
parameter space expands.
One parameter of note is k4, which was deemed to be locally sensitive, but globally
insensitive. The parameter k4 measures the one-to-one interaction between MMPs
and TIMPs. Muller suggests that these proteins are not only important to differences
in the healing response of these wounds, but also their interactions, as measured
by the ratio of the concentrations two proteins. Thus, it would be reasonable to
conclude that the interaction term and corresponding parameter value k4 should play
a significant role in the healing response of the wound. This is supported by the local
sensitivity measurement. However, the global insensitivity combined with the likely
importance of the parameter and local sensitivity indicates that there may only be a
small physiological range in parameter space for which the parameter is sensitive.
This result suggests that great care may need to be taken when selecting a range
of values to be used with global sensitivity analysis methods. This may even be
particularly important for terms with nonlinearities and high degrees of interactions.
For example, there may be large regions of parameter space where k4 is insensitive
since small values of either the MMPs or TIMPs will define k4 to be insensitive as
the interaction term becomes negligible.
While combining the LHS scheme with a PRCC analysis, further exploration
of parameter space may need to be considered before classifying the parameter as
insensitive, especially if the parameter could be significant to the biological problem.
As our local-to-global analysis indicates, this could be done by analyzing the LHS
scheme with the PRCC procedure for a narrow range around a measured parameter
value. If it is difficult to measure the parameter value, then the LHS scheme and
PRCC analysis could still be utilized to explore and perhaps identify smaller ranges
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where a parameter may be classified as a sensitive. These windows of sensitivity could
then, in turn, either be used to better select parameter values in the absence of data
or provide bounds when using a constrained optimizing routine with data.
2.4.4 Limitations
One limitation in our study is the spareness of the protein and cell data. In
general, it is difficult to obtain time-course data in a wound environment. The only
data from the literature we use to model are averaged MMP-1 and TIMP-1 levels and
wound closure, in which we assume that ECM levels are proportional to the closure.
Ideally we would be able to test the predictive ability of our model with individual
patient data. However, the steady-state analysis and the global sensitivity analysis
are independent of specific parameter estimates and data, allowing us to draw broad
conclusions about the biology of the wound. The local-to-global analysis verified
the results of the local sensitivity analysis, supporting the results of the parameter
estimation.
2.4.5 Future work
The solution to an inverse problem, as presented in this work, can be compu-
tationally expensive. Especially with a complex model and sparse data, estimating
all model parameters is often not possible [26]. Finding a subset of parameters or
the dependencies of unidentifiable parameters that can be reliably estimated involves
model identifiability [6].
The sensitivity analyses in this work were used to distinguish “sensitive” and “in-
sensitive” parameters. The analyses can also be viewed as numerical approaches to
identifiability analyses, with the identifiable parameters being a subset of the sensitive
parameters. Further examination of model identifiability in the future is warranted.
Additionally, the strong distinctions between the good and poor healers shown here
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suggest that further extensions of the model may be useful in assisting in distinguish-
ing patient categories in practice. Examining how the model parameters vary across
the population using individual patient data would be an important first step in this
direction.
CHAPTER 3
Extended TGF-β Model
To improve upon the model presented, we incorporate the role of transforming
growth factor beta (TGF-β) into the previous model. This cytokine plays a role as a
mediator in a variety of processes around the body. Each of the three isoforms acts
on various cell types, including fibroblasts, to modulate production and activity of
the biological components they affect [40, 30]. In orchestrating the overall process,
this growth factor has been shown to have great effect on the success of the healing
process. Incorporation of the effect that it plays in relation to the function of each
component presented for the four–variable model in equations 2.5 – 2.8 allows for
further description of the activity in the wound, and better coupling of the equations.
3.1 Model Equations
Equation for matrix metalloproteinases (M) TGF-β down–regulates the pro-
duction and activation of proteases, including MMP–1 [2]. To incorporate this effect,
we modify the production term of equation (2.5) through the addition of a term in the
denominator, causing high levels of TGF-β to decrease production of MMPs. Adding
this assumption, we have:
dM
dt
=
k1M
αf
kα2 +M
α(1 + k19β)︸ ︷︷ ︸
Production
− k3M︸︷︷︸
Decay
− k4MT︸ ︷︷ ︸
Inhibition
. (3.1)
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Equation for tissue inhibitors of matrix metalloproteinases (T ) The role of
TGF-β in modification of TIMP activity is opposite in nature – TGF-β up–regulates
the production of protease inhibitors, including TIMPs, and was therefore added as a
term in the numerator of the production term of equation (2.6) [2]. The exponent of
the Hill function was changed to γ for notational simplicity in this extended model.
We thus have:
dT
dt
=
(k5T
γfM)(1 + k17β)
kγ2 + T
γ︸ ︷︷ ︸
Production
− k7T︸︷︷︸
Decay
− k4MT︸ ︷︷ ︸
Inhibition
. (3.2)
Equation for extracellular matrix (E) The modulation of ECM levels by TGF-
β was found to upregulate the synthesis and production of ECM [2, 40]. The modified
form of equation (2.7) is:
dE
dt
= (k8 + k18β)f
(
1− E
E0
)
︸ ︷︷ ︸
Production
− k9ME︸ ︷︷ ︸
Degradation
− k10E︸︷︷︸
Decay
. (3.3)
Equation for fibroblasts (f) Fibroblast recruitment and proliferation is strongly
upregulated by the presence of TGF-β, and is reflected through the modification of
equation (2.8) [2, 40]:
df
dt
= (k11 + k13β)f
(
1− f
f0
)
︸ ︷︷ ︸
Production
− k12f︸︷︷︸
Death
. (3.4)
Equation for transforming growth factor (β) To model the activity of TGF-β
itself, we use an equation with two terms. The first, a production term utilizes a Hill
function with exponent δ to model the enzymatic production by fibroblasts. Decay of
TGF-β was modeled with rate constant k16, assuming that the growth factor decays
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at a constant rate [2, 30]. Thus we have:
dβ
dt
=
k14β
δf
kδ15 + β
δ︸ ︷︷ ︸
Production
− k16β︸︷︷︸
Death
. (3.5)
The incorporation TGF–β further couples the equations by including a crucial
biological factor that plays a role in the production, activation and activity of each of
the components in a wound, thus providing a more complete picture of the wound–
healing process.
3.1.1 Nondimensionalization
To nondimensionalize equations (3.1)− (3.5), we scale the MMP-1 and TIMP-1 levels
by the initial concentration of TIMP-1 at Week 0 (Tinit), the ECM, fibroblasts, and
TGF−β by their carrying capacities E0, f0, and β0, respectively, and time by t0 = 1
day. Under these conditions, nondimensionalized variables and parameters (labeled
with a *) are:
{M∗, T ∗, E∗, f ∗β∗, t∗} =
{
M
Tinit
,
T
Tinit
,
E
E0
,
f
f0
,
β
β0
,
t
t0
}
, (3.6)
{k∗1, k∗2, k∗3, k∗4, k∗5, k∗6} =
{
k1f0t0
Tinit
,
k2
Tinit
, k3t0, k4t0Tinit, k5f0t0,
k6
Tinit
}
,
{k∗7, k∗8, k∗9, k∗10, k∗11, k∗12} =
{
k7t0,
k8f0t0
E0
, k9t0Tinit, k10t0, k11t0, k12t0
}
,
{k∗13, k∗14, k∗15, k∗16, k∗17, k∗18, k∗19} =
{
k13
β0
,
k14f0t0
β0
,
k15
β0
, k16t0, k17β0,
k18f0t0β0
E0
, k19β0
}
.
(3.7)
Rewriting our extended model in terms of the dimensionless variables and pa-
rameters (and removing * for simplicity) gives the following system of differential
equations:
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dM
dt
=
k1M
αf
(kα2 +M
α)(1 + k19β)
− k3M − k4MT, (3.8)
dT
dt
=
(k5T
γfM)(1 + k17β)
kγ6 + T
γ
− k7T − k4MT, (3.9)
dE
dt
= (k8 + k18β)f(1− E)− k9ME − k10E, (3.10)
df
dt
= (k11 + k13β)f(1− f)− k12f, (3.11)
dβ
dt
=
k14β
δf
kδ15 + β
δ
− k16β, (3.12)
together with the initial conditions
M(0) =
Minit
Tinit
, T (0) = 1, E(0) = 0, f(0) = fi, β(0) = βi (3.13)
In terms of equations (2.1) and (2.2), the state vector is ~x = (M∗, T ∗, E∗, f ∗, β∗)
with length n = 5. The model output vector is ~y = (M∗, T ∗, E∗) with length m = 3.
Our model has q = 19 parameters, given by
θ = (k∗1, k
∗
2, k
∗
3, k
∗
4, k
∗
5, k
∗
6, k
∗
7, k
∗
8, k
∗
9, k
∗
10, k
∗
11, k
∗
12, k
∗
13, k
∗
14, k
∗
15, k
∗
16, k
∗
17, k
∗
18, k
∗
19)
T . (3.14)
Nondimensionalized equations (3.8) − (3.12) were chosen as the simplest system of
equations that capture the key fundamental mechanisms of healing in diabetic foot
ulcers.
3.2 Parameter Estimation
For the extended TGF-β model, we used the same routine as outlined in sec-
tion 2.2.3, once again using ranges for parameter estimation from 0 to 200 for each
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Table 3.1: Parameter estimates for the extended TGF-β model. The J –values indicate
a very good agreement between the model and data for the good healers and excellent
agreement for the poor healers.
Parameter Good Healers Poor Healers
k1 26.7681 1.383
k2 2.75177 0.6245
k3 0.0813146 0.3062
k4 0.691164 0.2413
k5 8.12821 1.5711
k6 0.102661 0.3166
k7 2.81192 5.0493
k8 146.125 0.245
k9 74.6642 0.0044
k10 2.08678 0.004
k11 3.57363 1.89
k12 0.669329 0.637
k13 2.09634 4.5519
k14 17.3593 0.3746
k15 153.221 0.5511
k16 10.0618 0.2164
k17 7.97833 17.1903
k18 11.9296 0.1125
k19 4.68642 1.3036
J 0.4959 0.0273
parameter. Parameter estimates with the best J–value are listed in Table 3.1. We
determined Hill function orders for the MMP and TIMP equations to be α = γ = 3,
and δ = 4 for the TGF-β equation. Initial values of 0.1 for fibroblasts and 0.5 for
TGF–β were used. Simulations using the parameter estimates are provided for good
healers (Figure 3.1) and poor healers (Figure 3.2). Simulations incorporating TGF–β
for good healers were not significantly different than those for the MMP–1/TIMP–1
model, as β ≈ 0 for t > 1 week.
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Figure 3.1: Good healer plots for the extended TGF–β model. Curves were generated
using Matlab’s ode15s with optimal parameter values.
CHAPTER 3. EXTENDED TGF-β MODEL 53
0 2 4 6 8 10 12
0
1
2
3
MMP
t
M
0 2 4 6 8 10 12
0
1
2
3
TIMP
t
T
0 2 4 6 8 10 12
0
0.5
1
ECM
t
E
0 2 4 6 8 10 12
0
0.5
1
Fibroblast
t
f
0 2 4 6 8 10 12
0
0.5
1
TGF−B
t
B
Figure 3.2: Poor healer plots for the extended TGF–β model. Curves were generated
using Matlab’s ode15s with optimal parameter values.
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3.3 Global Sensitivity Analysis
The LHS/PRCC procedure was performed to assess the extended TGF-β model
using the method listed in 2.2.6. Monotonicity was confirmed for both sets of param-
eter estimates. PRCC plots are provided in Figures 3.3 – 3.7.
Parameters were classified as significantly sensitive to a state variable if the re-
spective PRCC was greater than the threshold sensitivity value of 4.75, calculated
using the a PRCC–value of 0.5 and p–value of 0.05. PRCC values were calculated
using Figures 3.3 – 3.7. For the TGF-β extended model, the sensitive parameters are:
k3 (M), k7 (T), k10 (E), k11 (E,f), k12 (E,f) (Table 3.2). No parameters were sensitive
with respect to the TGF-β equation.
To assess the overall sensitivities of each parameter, we calculate the total sensi-
tivity using 2.18. Total sensitivity was found with respect to all state parameters, as
well as to only those for which data was recorded. Parameters sensitive to a single
state variable correlated to the most sensitive parameters overall (Table 3.3).
3.4 Discussion
Biologically, we can highlight aspects of the simulations for each sub–group of
healers.
For the good healers, it was noted that levels of TGF–β decline to negligble
amounts within week 1, eliminating the added effect of the cytokine (Figure 3.1).
The solver may have converged to the solution that was most similar to the param-
eter estimates for the MMP–1/TIMP–1 model. Using these estimates, parameters
estimates associated with TGF–β that would result in low amounts would result in
the lowest error, thus making these parameters somewhat unidentifiable, as can be
noted in the extreme differences in the magnitudes of these parameters relative to
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Figure 3.3: PRCC plots for each parameter with respect to M for the extended TGF-β
model.
CHAPTER 3. EXTENDED TGF-β MODEL 56
−
5
0
5
−
20
−
10010
k1
−
10
−
5
0
5
−
10010
k2
−
10
−
5
0
5
−
20
−
10010
k3
−
5
0
5
−
20020
k4
−
5
0
5
−
1001020
k5
−
10
0
10
−
20020
k6
−
20
−
10
0
10
−
20020
k7
−
5
0
5
−
1001020
k8
−
5
0
5
−
1001020
k9
−
10
−
5
0
5
−
10010
k10
−
5
0
5
10
−
20020
k11
−
5
0
5
−
10010
k12
−
10
−
5
0
5
−
10010
k13
−
10
−
5
0
5
−
20020
k14
−
5
0
5
−
20020
k15
−
5
0
5
−
20020
k16
−
5
0
5
−
20020
k17
−
5
0
5
−
20
−
10010
k18
−
5
0
5
−
20020
k19
Figure 3.4: PRCC plots for each parameter with respect to T for the extended TGF-β
model.
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Figure 3.5: PRCC plots for each parameter with respect to E for the extended TGF-β
model.
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Figure 3.6: PRCC plots for each parameter with respect to f for the extended TGF-β
model.
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Figure 3.7: PRCC plots for each parameter with respect to β for the extended TGF-β
model.
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Table 3.2: Total sensitivity values, extended TGF-β model. Bolded parameters meet
the threshold for sensitivity, S ≥ 4.75.
Parameter SM ST SE Sf Sβ
k1 2.697 3.283 2.723 2.962 2.962
k2 2.502 2.864 2.658 2.936 2.415
k3 8.513 2.642 2.825 2.798 2.807
k4 2.630 2.737 3.001 2.890 2.785
k5 2.899 2.935 2.726 2.806 2.799
k6 2.897 3.166 2.822 2.967 2.670
k7 3.199 8.651 2.619 2.607 2.792
k8 2.659 2.754 4.447 2.751 2.505
k9 2.726 3.000 2.666 2.634 2.227
k10 2.485 2.877 5.267 2.833 2.420
k11 2.698 2.989 8.072 8.963 2.987
k12 2.643 2.976 8.544 9.430 2.704
k13 2.862 3.291 2.715 2.614 2.421
k14 2.426 2.942 2.717 2.536 2.615
k15 2.152 2.958 2.962 2.635 2.779
k16 2.710 2.829 2.707 2.711 2.890
k17 2.445 2.638 2.306 2.381 2.772
k18 2.553 2.799 2.689 2.697 2.754
k19 2.641 2.922 2.567 2.640 2.792
CHAPTER 3. EXTENDED TGF-β MODEL 61
Table 3.3: Ranked total sensitivity values with respect to all and to observed state
variables for the extended TGF-β model. Total sensitivity values are shown ranked
by sensitivity with respect to observed state variables. Bolded parameters indicate
those classified as sensitive.
PRCCMTEfB PRCCMTE
k7 10.321 9.588
k12 13.604 9.425
k3 10.156 9.351
k11 13.063 9.021
k10 7.489 6.496
k8 6.948 5.867
k13 6.253 5.138
k6 6.505 5.136
k1 6.558 5.046
k5 6.337 4.944
k9 5.953 4.852
k4 6.287 4.839
k16 6.195 4.762
k15 6.068 4.706
k19 6.072 4.701
k14 5.932 4.682
k18 6.036 4.645
k2 5.998 4.640
k17 5.622 4.273
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the poor healer sub–group or previous simulations (not included). We can make hy-
pothetical conclusions about this result; perhaps in good healers there is a different
cytokine which plays a more dominant role than TGF–β. Even so, further simulations
may provide better simulations for this sub–group.
For poor healers, we see a significantly closer fit to the data, reflected in both the
J–value (Table 3.1) and simulated plots (Figure 3.2). There is a loss of TIMPs in
the first two weeks of healing that is not observed in the data, but is reflected in our
simulations. The cause of this oscillation can be described through the parameter
estimates for k7, the parameter controlling the decay of TIMPs. In good healers, this
value is smaller in magnitude than for poor healers, indicating that there may be an
increased rate of TIMP decay, which is able to dominate the change in the TIMPs
until sufficient fibroblast recruitment has occurred that proliferation and activation
of the enzyme balances and overcomes the losses through decay.
Through in–vivo studies, it was found that concentrations of TGF–β levels in the
wound fluid tended to peak at day 7 of wound healing, remaining at that elevated
level until at least day 16 of healing [2]. This trend was observed for poor healers,
but not for good healers, for which we see levels decline rapidly to neglible in week
1 of healing. This further supports the validity of the estimates found for the poor
healers.
In general, the identifiability of the model can be described for select parameters.
For the extended model, we specifically assess the characteristics of k15, the term
in the denominator of the Hill function for the TGF–β equation. For k15  β,
the Hill function can be assessed as a linear term with coefficient k14/k
δ
15. This
pairing creates an identifiable combination, for which the parameter estimate can be
determined as a combination, yet each individual can vary with respect to the other.
This causes difficulties when attempting to estimate all parameters at once using
numerical techniques, such as Matlab.
CHAPTER 3. EXTENDED TGF-β MODEL 63
In addition, the model was not significantly sensitive to any parameters added
to describe the effects of TGF–β. This further exacerbates the difficulty of estimat-
ing these parameters. Even so, the model has great potential to improve upon the
predictive power of the MMP–1/TIMP–1 model. Further work with this model will
include using the results of this analysis to determine better parameter estimates for
the model.
CHAPTER 4
Bacterial Infection Model
For a qualitative approach, the healing of a wound can be represented by the inflam-
matory responses at the wound. The model, developed by Dr. Richard Schugart,
describes the interactions of neutrophils, which constitute a major portion of the
body’s first defense against infection, with bacteria and oxygen in the wound site.
This qualititative model uses estimates for parameter values from Schugart et al.
(2008) and Ward et al. (2001). This model may be used in the future to formulate a
quantitative model for a bacterial infection through work with collaborators to obtain
biological data. This work is to be included in a manuscript currently in progress,
written by Dr. Schugart and his students.
4.1 Model Equations
The nondimensionalized model is as follows.
Equation for neutrophils (n) The level of neutrophils is denoted by n. The
activation, recuitment and death are modeled.
dn
dt
= knpe
−λpt︸ ︷︷ ︸
neutrophil activation
+ kbnbngnw(w))(1− n)︸ ︷︷ ︸
recuitment
− λn(1 + hnw(w))n
1 + eb︸ ︷︷ ︸
apoptosis
(4.1)
where
gnw(w) = (2w
3 − 3w2 + 1)H(1− w), (4.2)
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hnw(w) = 2H(w − 3) + 2H(0.2− w), (4.3)
and H is the Heaviside function,
H(x) =

0 if x < 0
1 if x ≥ 0.
(4.4)
As a smooth approximation of Heaviside function, we use
H˜ (x) =
arctan (1000x)
pi
+
1
2
. (4.5)
Equation for bacteria (b) The density of bacteria is denoted by b. Proliferation
is modeled logistically, while bacteria loss or death occurs through oxidative killing.
db
dt
= kbb(1− b)︸ ︷︷ ︸
bacterial proliferation
− δ + knrn
λbrb+ 1
grw(w)b︸ ︷︷ ︸
oxidative killing by neutrophils
(4.6)
where
grw(w) =
w
Kw + w
(4.7)
Equation for oxygen (w) Oxygen concentration in the wound is denoted by w.
Diffusion of oxygen into the wound from surrounding tissue is represented by β.
While the model includes a term for oxygen therapy, we simulate the healing with no
external input of oxygen, setting G(t) = 0. Uptake of oxygen by each of the other
components is assumed directly proportional to levels of the respective component.
Decay of oxygen is also included.
dw
dt
= β︸︷︷︸
diffusion
+ γG(t)︸ ︷︷ ︸
external oxygen
− λnwnw − λbwbw︸ ︷︷ ︸
uptake by neutrophils and bacteria
−λww︸︷︷︸
decay
(4.8)
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Table 4.1: Nondimesionalized values for parameters of the bacterial infection model
estimated in the literature. Ranges shown were used for the LHS/PRCC procedure.
Param Param Est Lower Bound Upper Bound
kb 14.256 0.0001 100
knr 69 0.0001 100
δ 14.4 0.0001 100
λrb 5.94 0.0001 100
kw 0.75 0.4 1
knp 5 0.0001 100
λp 3.04 0.0001 100
kbn 5 0.0001 100
λn 0.1728 0.0001 100
β 0.7992 0.0001 100
λw 1.0656 0.0001 100
λbw 12.659328 0.0001 100
λnw 25.5744 0.0001 100
 0.01 0.001 0.1
4.2 Global Sensitivity Analysis
A LHS/PRCC procedure was conducted for the bacterial infection model. Pa-
rameters were estimated by Dr. Schugart. Ranges for the parameter spaces are listed
in table 4.1.
PRCC values were calculated using Figures 4.1 – 4.3. Sensitive parameters for
this model with respect to each state variable are as follows: kb (b), δ (b), knp (n),
λp (n), λn (n), β (b,w), λw (b,w) (Table 4.2). Total sensitivity rankings with respect
to all state variables were calculated. Parameters sensitive to a single state variable
were the overall most sensitive parameters (Table 4.3).
4.3 Discussion
For this qualitative model, determining sensitive parameters can indicate terms
which may need special attention when designing data collection techniques. Knowing
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Table 4.2: Total sensitivity values with respect to each state variable for the bacterial
infection model. Bolded parameters indicate those classified as sensitive.
n b w
kb 3.084 9.489 3.218
knr 2.211 4.005 2.479
δ 2.113 8.472 3.164
λrb 2.051 2.330 1.928
kw 2.129 4.020 2.641
knp 8.101 3.404 3.287
λp 8.481 2.947 4.091
kbn 2.527 2.423 2.648
λn 7.641 2.768 3.059
β 2.381 6.396 9.047
λw 1.931 5.335 8.549
λbw 2.240 2.569 2.846
λnw 2.029 2.433 3.474
 2.637 2.267 2.114
Table 4.3: Total sensitivity values with respect to all state variables for the bacterial
infection extended model. Bolded parameters indicate those classified as sensitive.
Total
β 11.3323
kb 10.4835
λw 10.2605
λp 9.8669
knp 9.3823
δ 9.2871
λn 8.6838
kw 5.2600
knr 5.2034
λnw 4.7018
λbw 4.4401
kbn 4.3893
 4.0700
λrb 3.6540
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Figure 4.1: PRCC plots for each parameter with respect to bacteria for the bacterial
infection model.
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Figure 4.2: PRCC plots for each parameter with respect to neutrophils for the bac-
terial infection model.
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Figure 4.3: PRCC plots for each parameter with respect to oxygen for the bacterial
infection model.
CHAPTER 4. BACTERIAL INFECTION MODEL 71
which processes the model is most sensitive to provides insight to the most important
interactions. For this model, terms associated with bacterial proliferation, oxidative
killing of bacteria, neutrophil activation and death, diffusion of oxygen and decay of
oxygen had the greatest effect on the outputs. The model was most sensitive to the
diffusion of oxygen into the wound site. The role of oxygen as a precursor for radicals
that act as bactericides is crucial to the ability of neutrophils to kill bacteria and
reduce inflammation [33, 41]. The importance of oxygen to the inflammatory process
contributes to the success of oxygen therapy, in which oxygen is applied topically to
the wound site to promote the oxidative killing, as well as the proliferation of other
cruicial enzymes, such as MMP.
CHAPTER 5
Conclusions and Further Work
We developed two models for matrix metalloproteinase and their inhibitors in a
wound. Parameter estimates were found for each model using “fmincon” and “Glob-
alSearch” in Matlab. Goodness of fit was numerically evaluated using a least–squares
functional. The parameter sets for poor healers had a slightly better fit, yet included
a discrepancy between model and data for TIMPs.
A bacterial infection model, alongside the two previously mentioned models, were
analyzed using the Latin Hypercube Sampling/Partial Rank Correlation Coefficient
procedure, which assessed uncertainty and provided numerical results describing sen-
sitivity of a non–linear model to a parameter, while withholding effects of other pa-
rameters. Results for the MMP models were similar. The modification of the TGF-β
model did not change the sensitive parameters, which included k7, k12, k3, and k11,
all terms associated with decay rates or production of fibroblasts.
Comparisons of rankings for this global analysis to results of the local sensitivity
analysis performed for the MMP four–variable model required the modification of the
parameter space to “local”. Once restricted to smaller regions of parameter space, re-
sults for the LHS/PRCC were exceedingly similar to those for the classical sensitivity
analysis. To determine where the sensitivity changed from local to global, we devel-
oped and conducted an analysis over a changing parameter space that shifted from
physiologically–significant local ranges to global parameter spaces used for parameter
estimation. This analysis has potential as a tool for other mathematical models.
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To the author and mentor’s knowledge, this is the first time that an analysis has
been developed and compared a local analysis to a global analysis, specifically by
assessing how the sensitivities differ over a changing local–to–global analysis. The
applications of this technique provide insight to the importance of the meaningful
parameter space and how it affects parameter sensitivity. Further development of
this analysis can possibly create a new tool for mathematical modeling to understand
the role of parameter space sensitivity, especially in determining ranges of uncertainty
for final parameter estimates.
Future analysis of each model will continue as follows.
Identifiability and predictibility of the MMP–1/TIMP–1 model will further dis-
tinguish sensitive parameters for the model and will help us understand the clinical
power of the model. We will further assess this using recently acquired individual
patient data.
Work on the extended TGF-β model will continue in order to find the best set
of model parameter estimations. The success of this model may provide a more
descriptive alternative to the MMP–1/TIMP–1 model. Understanding the sensitivity
using the local–to–global analysis may provide insight to better parameter spaces to
use for further parameter estimation.
For the bacterial infection model, the results of this analysis will be used in the
development of an experiment to acquire data. Once quantitative methods for pa-
rameter estimation are applied and compared to previous estimates, the integration of
oxygen therapy as a model variable can be used to make the model a tool in predicting
healing response of an individual to the therapy.
For the bacterial infection model, the results of this analysis will be used in the
development of an experiment to acquire data. Once quantitative methods for pa-
rameter estimation are applied and compared to previous estimates, the integration
of oxygen therapy as a model variable can be done to make the model a tool in
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predicting healing response of an individual to the therapy.
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